project id: TCGA-BLCA; case submitter id: TCGA-H4-A2HO; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.4; age at index: 53; days to birth: -19630; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 19630; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 46.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 421; days to sample procurement: 0; portion submitter id: TCGA-H4-A2HO-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 24.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;